1. Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure
   M Wattad et al, 2017, Leukemia CrossRef
2. Fludarabine, High Dose Cytarabine and Granulocyte Colony-Stimulating Factor (FLAG) as Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia: A Retrospective Cohort Study
   Kian Boon Law et al, 2017, Indian Journal of Hematology and Blood Transfusion CrossRef
3. Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy
   Regina Mühleck et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
4. How I treat refractory and early relapsed acute myeloid leukemia
   Felicitas Thol et al, 2015, Blood CrossRef
5. The fludarabine, cytarabine, and granulocyte colony‐stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline‐based therapy for the treatment of acute myeloid leukemia for patients with pre‐existing cardiac disease
   Lalit Saini et al, 2016, European Journal of Haematology CrossRef
6. Wilms tumour 1 peptide vaccine as a cure‐oriented post‐chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse
   Jun Nakata et al, 2018, British Journal of Haematology CrossRef
7. Re-induction chemotherapy using FLAG–mitoxantrone for adult patients with relapsed acute leukemia: a single-center experience from United Arab Emirates
   Inaam Bashir Hassan et al, 2018, International Journal of Hematology CrossRef
8. Salvage regimens using conventional chemotherapy agents for relapsed/refractory adult AML patients: a systematic literature review
   Juan Eduardo Megías-Vericat et al, 2018, Annals of Hematology CrossRef
9. Retrospective Comparison of Fludarabine in Combination With Intermediate-Dose Cytarabine Versus High-Dose Cytarabine As Consolidation Therapies for Acute Myeloid Leukemia
   Wenjun Zhang et al, 2014, Medicine CrossRef
10. Relapsed and Refractory Pediatric Acute Myeloid Leukemia: Current and Emerging Treatments
    Jennifer Davila et al, 2014, Pediatric Drugs CrossRef
11. Efficacy and safety of chemotherapy combined with different doses of IL-2 maintenance therapies for acute myeloid leukemia
    Xuewei Yin et al, 2021, Medicine CrossRef
12. Long‐term follow‐up of Cladribine, high‐dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review
    Karin Mayer et al, 2020, European Journal of Haematology CrossRef